Medpace Holdings, Inc. · NASDAQ:MEDP
Medpace — Fact Sheet (March 2023)
1 slide from Medpace's fact sheet, March 2023
Slide 1: Your CRO Partner for Cellular & Gene Therapy Clinical Development
YOUR CRO PARTNER FOR CELLULAR & GENE THERAPY CLINICAL DEVELOPMENT Medpace has contributed to over 130 cellular and gene therapy clinical trials. Our experienced team of experts take an active role in the field and are at the forefront of rapidly changing clinical and regulatory developments. TRIBUTED